Abstract
The notion that protein-coding genes are the only biologically significant moieties in the genome is revolutionarized by the discovery of non-coding RNAs. Among them is a group of small non-coding RNAs termed microRNAs (miRNAs) that has recently been brought to the limelight. Their presence in the genome was only realized after the identification of their founders lin-4 and let-7 in C. elegans through genetic screens. To date, several hundreds of microRNAs have been identified. They are single-stranded RNA molecules of ∼21-22 nucleotides long, excised from precursors of ∼70 nucleotides predicted in silico to from imperfect stem-loop structures. Many of these miRNAs are evolutionarily conserved, implicating important biological functions. Emerging data points to an important role of these tiny RNA molecules in regulating gene expression of target RNAs by at least two post-transcriptional mechanisms: binding to imperfect complementary sequence of the 3 untranslated region (3UTR) and repressing translation; and endonucleolytic cleavage by a double-stranded RNA-mediated interference (RNAi) mechanism through base-pairing with perfect or near-perfect complementary sequence. Studies in several miRNAs in plants and animals illustrate that these small riboregulators can play critical roles in developmental timing and spatial control of cell fate decisions, cell proliferation, apoptosis, cell differentiation and cell metabolism. Developmental defects and tumorigenesis can be a consequence of abnormal expression of miRNAs. This review discusses the biological functions, mechanisms of action, biogenesis and regulation of miRNAs, as well as identification of their target genes, highlighting the potential diversity of this novel class of gene regulators.
Keywords: microrna, gene regulation, untranslated region, translation
Current Genomics
Title: MicroRNAs: Tiny but Not Trivial
Volume: 5 Issue: 3
Author(s): Wayne Tam
Affiliation:
Keywords: microrna, gene regulation, untranslated region, translation
Abstract: The notion that protein-coding genes are the only biologically significant moieties in the genome is revolutionarized by the discovery of non-coding RNAs. Among them is a group of small non-coding RNAs termed microRNAs (miRNAs) that has recently been brought to the limelight. Their presence in the genome was only realized after the identification of their founders lin-4 and let-7 in C. elegans through genetic screens. To date, several hundreds of microRNAs have been identified. They are single-stranded RNA molecules of ∼21-22 nucleotides long, excised from precursors of ∼70 nucleotides predicted in silico to from imperfect stem-loop structures. Many of these miRNAs are evolutionarily conserved, implicating important biological functions. Emerging data points to an important role of these tiny RNA molecules in regulating gene expression of target RNAs by at least two post-transcriptional mechanisms: binding to imperfect complementary sequence of the 3 untranslated region (3UTR) and repressing translation; and endonucleolytic cleavage by a double-stranded RNA-mediated interference (RNAi) mechanism through base-pairing with perfect or near-perfect complementary sequence. Studies in several miRNAs in plants and animals illustrate that these small riboregulators can play critical roles in developmental timing and spatial control of cell fate decisions, cell proliferation, apoptosis, cell differentiation and cell metabolism. Developmental defects and tumorigenesis can be a consequence of abnormal expression of miRNAs. This review discusses the biological functions, mechanisms of action, biogenesis and regulation of miRNAs, as well as identification of their target genes, highlighting the potential diversity of this novel class of gene regulators.
Export Options
About this article
Cite this article as:
Tam Wayne, MicroRNAs: Tiny but Not Trivial, Current Genomics 2004; 5 (3) . https://dx.doi.org/10.2174/1389202043349435
DOI https://dx.doi.org/10.2174/1389202043349435 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Clinical Update: Treatment of Glioblastoma Multiforme with Radiolabeled Antibodies that Target Tumor Necrosis
Current Cancer Therapy Reviews Recent Developments in Receptor-Selective Retinoids
Current Pharmaceutical Design Synthesis of Cis-Fused Pyran Indolocarbazole Derivatives that Inhibit FLT3 Kinase and the DNA Damage Kinase, Checkpoint Kinase 1
Anti-Cancer Agents in Medicinal Chemistry CD26 / Dipeptidyl Peptidase IV: A Regulator of Immune Function and a Potential Molecular Target for Therapy
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Gene Expression and Behavior Analysis of PC12 Cells Grown on Synthetic Biodegradable Fibrous Membranes Coated with Natural Biopolymers
Current Nanoscience Methodological Aspects and Applications of In Vivo Imaging of Apoptosis in Oncology: An Illustrative Review
Current Medical Imaging Effect and Mechanism of Curcumin on EZH2 - miR-101 Regulatory Feedback Loop in Multiple Myeloma
Current Pharmaceutical Design Novel Approaches in the Synthesis of Batracylin and Its Analogs: Rebirth of an Old Player?
Current Medicinal Chemistry Voltage-Dependent Potassium Channels Kv1.3 and Kv1.5 in Human Cancer
Current Cancer Drug Targets Resistance to Crizotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) with ALK Rearrangement: Mechanisms, Treatment Strategies and New Targeted Therapies
Current Clinical Pharmacology Development of PET Probes for Cancer Imaging
Current Topics in Medicinal Chemistry Management of Inflammation by Natural Polyphenols: A Comprehensive Mechanistic Update
Current Medicinal Chemistry The Role of Apoptosis in Cancer Development and Treatment: Focusing on the Development and Treatment of Hematologic Malignancies
Current Pharmaceutical Design <i>Prunella vulgaris</i> L: Critical Pharmacological, Expository Traditional Uses and Extensive Phytochemistry: A Review
Current Drug Discovery Technologies SELDI Protein Chip Technology for the Detection of Serum Biomarkers for Liver Disease
Protein & Peptide Letters Natural Products Based Anticancer Agents
Mini-Reviews in Organic Chemistry EZN-2208 (PEG-SN38), A 40 kDa Polyethylene Glycol (PEG) Conjugate, As an Anticancer Agent: Review of Preclinical and Clinical Data
Current Bioactive Compounds Understanding the Role of Poloxamer 407 based Thermoreversible In Situ Gelling Hydrogel for Delivery of PEGylated Melphalan Conjugate
Current Drug Delivery Exploring Proteomic Drug Targets, Therapeutic Strategies and Protein - Protein Interactions in Cancer: Mechanistic View
Current Cancer Drug Targets Pharmacological Inhibition of the Bcl-2 Family of Apoptosis Regulators as Cancer Therapy
Current Molecular Pharmacology